Merrimack Pharmaceuticals, Inc. carries a market capitalization of 223.97M, placing it among publicly traded companies globally.
| Market Cap | 223.97M |
| Enterprise Value | N/A |
Merrimack Pharmaceuticals, Inc.'s stock has gained approximately 21.54896% over the past 52 weeks. The 50-day moving average sits at 14.80, while the 200-day moving average is 13.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | 21.54896% |
| 50-Day Moving Average | 14.80 |
| 200-Day Moving Average | 13.36 |
| Average Volume (20 Days) | N/A |
Merrimack Pharmaceuticals, Inc.'s most recent stock split took place on September 6, 2019 with a 1000:1271 split ratio.
| Last Split Date | 9/6/2019 |
| Split Ratio | 1000:1271 |